4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation

Overview of attention for article published in Frontiers in immunology, April 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 32,773 followers.

RT @FrontImmunol: New Research: 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilit…

RT @FrontImmunol: New Research: 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilit…

RT @FrontImmunol: New Research: 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilit…

RT @FrontImmunol: New Research: 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilit…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.